Novartis India: Small Cap Pharma Stock Trading Ex-Dividend Next Week for Rs 47.50/Share Dividend

Rajesh
0

Novartis India Ltd, a small-cap pharmaceutical company, is gearing up to trade ex-dividend on July 20, 2023. Shareholders can look forward to a 750% special dividend and a 200% final dividend. The company had declared a total dividend of Rs 47.50 per equity share with a face value of Rs 5 each on May 10, 2023. Currently, Novartis India shares are valued at Rs 862.50 per share on the Bombay Stock Exchange (BSE). Over the past three months, Novartis India stock has generated a remarkable return of 44%. Here are further details:

Novartis India: Small Cap Pharma Stock Trading Ex-Dividend Next Week for Rs 47.50/Share Dividend

Novartis India Set to Go Ex-Dividend on July 20: According to the regulatory filing of Novartis India, the company's Board has recommended the following dividends for the financial year ended March 31, 2023, subject to the approval of the shareholders at the upcoming Annual General Meeting (AGM):

a) Final dividend of Rs 10.00 per equity share with a face value of Rs 5 each.

b) One-time special dividend of Rs 37.50 per equity share with a face value of Rs 5 each, in celebration of the company's 75th Anniversary.

The total dividend amounts to Rs 47.50 per equity share with a face value of Rs 5 each. If approved by the shareholders, the dividend will be paid on or after August 02, 2023.

Novartis India Stock Performance & Return: As of the latest data, Novartis India shares are priced at Rs 861.35 per share on the BSE, showing an intraday gain of 0.25%. The stock's 52-week high and low prices stand at Rs 876.45 per share and Rs 554.00 per share, respectively. With a market capitalization of Rs 2126.74 crore, Novartis India has recorded a year-to-date (YTD) increase of 28%, a one-year return of 29%, a two-year decrease of 12%, and an impressive three-year return of 52%.

Novartis India Financial Performance: For the quarter ended March 31, 2023, Novartis India announced a standalone total income of Rs 92.50 crore, representing a 4.48% increase compared to the previous quarter's total income of Rs 88.53 crore. The company reported a net profit after tax of Rs 25.02 crore for the recent quarter.

About Novartis India: Novartis India, headquartered in Basel, Switzerland, is a leading global medicines company. It specializes in discovering and developing breakthrough treatments and strives to make them accessible to as many people as possible. The company leverages innovative science and digital technologies to create transformative treatments that address significant medical needs. To learn more about Novartis India, please visit their official website.

Disclaimer: 

The information provided in this article is for informational purposes only. It should not be construed as financial advice or a recommendation to buy or sell any securities. Investing in stocks involves risks, and readers are advised to conduct their own research and consult with a qualified financial advisor before making any investment decisions. The accuracy, completeness, or reliability of the information mentioned in this article is not guaranteed. The author shall not be held responsible for any losses, damages, or liabilities arising from the use of this information.

Read Also : Tesla Explores Partnership with Indian Government for EV Manufacturing Plant.

Tags

Post a Comment

0Comments
Post a Comment (0)